Comparative study of the safety and therapeutic efficacy of oral steroids (betamethasone) in pulse dose and oral cyclosporine in the treatment of alopecia areata (patchy hair loss).
Phase 2
Completed
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2019/01/017202
- Lead Sponsor
- Shibashis Chatterjee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1.Patients consenting for the study.
2.All the patients presenting with circumscribed patch of hair loss without any signs of inflammation or scarring,of size > 3cm in diameter.
3.Patients who have symptoms of 3 months or more duration.
4.Patients who have not taken any other modalities of treatment in the last 3 months.
Exclusion Criteria
1.Patients who are k/c/o hypertension.
2.Patients with secondary infection.
3.Pregnant and lactating females.
4.Patients with pre-existing renal and liver diseases.
5.Patients with diabetes mellitus.
6.Patients having any Autoimmune disease like SLE, Sjogrenâ??s Syndrome,etc.
7.Patients having contraindications to the drugs used in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety of the drugsTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method Therapeutic efficacy of the drugsTimepoint: 3 months